Published in Clin Exp Immunol on July 01, 1998
Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J Leukoc Biol (2009) 1.51
Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun (2001) 1.37
Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS One (2008) 1.17
IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J Immunol (2011) 1.08
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart (2007) 1.04
Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta. Am J Physiol Heart Circ Physiol (2010) 0.97
Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors. J Leukoc Biol (2014) 0.92
Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons? Front Immunol (2013) 0.92
Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages. Clin Exp Immunol (1999) 0.88
Metallothionein-1 and nitric oxide expression are inversely correlated in a murine model of Chagas disease. Mem Inst Oswaldo Cruz (2014) 0.75
Inverse Correlation between IL-10 and HIF-1α in Macrophages Infected with Histoplasma capsulatum. J Immunol (2016) 0.75
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
Nitric oxide and macrophage function. Annu Rev Immunol (1997) 12.77
Macrophage deactivation by interleukin 10. J Exp Med (1991) 6.94
Interleukin 10 protects mice from lethal endotoxemia. J Exp Med (1993) 4.46
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med (1993) 4.30
Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest (1995) 3.43
Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J Immunol (1990) 2.79
Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol (1995) 2.51
IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol (1997) 2.50
IL-10: a novel cytotoxic T cell differentiation factor. J Immunol (1991) 2.32
Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol (1996) 2.31
Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun (1993) 2.10
Role of nitric oxide in parasitic infections. Microbiol Rev (1995) 1.91
Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis (1996) 1.88
IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol (1993) 1.87
Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol (1994) 1.72
Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Exp Parasitol (1996) 1.62
The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi. J Protozool (1972) 1.58
IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol (1992) 1.51
Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun (1997) 1.44
Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol (1996) 1.42
IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol (1997) 1.38
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J Exp Med (1996) 1.29
Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol (1995) 1.27
The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood (1995) 1.26
Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10. Eur J Immunol (1993) 1.12
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect Immun (1996) 1.06
Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem Biophys Res Commun (1994) 1.05
Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol (1995) 1.02
Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunol (1994) 1.02
Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection. Immunology (1995) 1.00
Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol (1989) 0.94
In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. J Immunol (1995) 0.93
Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice. Infect Immun (1996) 0.88
Modulation of nitric oxide synthase activity in macrophages. Mediators Inflamm (1995) 0.86
Opposing effects of interleukin-10 on mouse macrophage functions. Scand J Immunol (1995) 0.81
Some characteristics of the hyperreactivity to bacterial lipopolysaccharide induced in mice by Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz (1985) 0.77
Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J Infect Dis (1997) 0.77
[Inhibitory effects of interleukin (IL) -10 and viral IL-10 (vIL-10) on the functions of monocytes/macrophages]. Nihon Rinsho Meneki Gakkai Kaishi (1995) 0.77
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med (1993) 4.30
Diaphragm function and alveolar hypoventilation. Q J Med (1976) 3.94
Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ (2000) 3.45
An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J Immunol (1976) 3.14
Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med (1994) 2.96
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia. Clin Infect Dis (1998) 2.78
Induction of thromboses within renal grafts by high-dose prophylactic OKT3. Lancet (1992) 2.66
Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol (2001) 2.56
Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun (1992) 2.50
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol (1989) 2.36
Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum (1997) 2.21
A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet (2001) 2.13
A simplified measurement of respiratory resistance by forced oscillation. J Appl Physiol (1970) 2.11
Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol (1991) 2.08
Interleukin-10 production during septicaemia. Lancet (1994) 2.05
Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology (1998) 2.04
Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol (1994) 2.04
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01
Validity of performance scales for disability assessment in multiple sclerosis. Mult Scler (2007) 1.99
Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol (2001) 1.96
Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol (1995) 1.94
A scanning electron microscopic comparison of a high volume final flush with several irrigating solutions: Part 3. J Endod (1983) 1.94
Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol (1994) 1.92
Spontaneous secretion of interferon gamma and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes. Gut (1998) 1.88
Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis (1996) 1.88
Basophil activation tests for the diagnosis of food allergy in children. Clin Exp Allergy (2009) 1.83
Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase. Proc Natl Acad Sci U S A (1980) 1.80
Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol (1982) 1.78
Investigation of the increased incidence of gonorrhoea diagnosed in genitourinary medicine clinics in England, 1994-6. Sex Transm Infect (2000) 1.78
Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology (1997) 1.73
Detection of blood chimerism after lung and heart-lung transplantation. The superiority of nested as compared with standard polymerase chain reaction amplification. Transplantation (1994) 1.69
Adolescents are not adults: developmental considerations in alcohol users. Alcohol Clin Exp Res (2000) 1.69
Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill (2011) 1.69
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg (1996) 1.63
Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev (1996) 1.59
Does 111indium-platelet deposition predict patency in prosthetic arterial grafts? Br J Surg (1983) 1.55
Intranasal midazolam as a treatment of autonomic crisis in patients with familial dysautonomia. Pediatr Neurol (2000) 1.52
An improved microfluorimeter for measuring brightness of fluorescent antibody reactions. J Histochem Cytochem (1967) 1.51
Abnormal T-cell phenotype in familial erythrophagocytic lymphohistiocytosis. Lancet (1993) 1.51
Transfusion-transmitted malaria in Canada. CMAJ (2001) 1.51
Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation (1989) 1.50
T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol (2005) 1.50
Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis. Lancet (1998) 1.49
Evaluation of a fluorescent antibody test for amebiasis using two widely differing ameba strains as antigen. Am J Trop Med Hyg (1966) 1.46
The global impact of the Chernobyl reactor accident. Science (1988) 1.44
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol (1993) 1.44
Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol (2000) 1.44
Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol (1995) 1.43
Low dose low osmolar intravenous urography. Clin Radiol (1987) 1.40
Effect of coadministration of a nutritional supplement on ciprofloxacin absorption. Am J Hosp Pharm (1994) 1.39
Bulging fontanelle in febrile infants: is lumbar puncture mandatory? Arch Dis Child (2009) 1.39
The assessment of diaphragm function. Medicine (Baltimore) (1977) 1.39
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy (2004) 1.38
Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol (1994) 1.37
Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology (1995) 1.37
Elective repair of groin hernias in the elderly. Br J Surg (1987) 1.36
Trusses. BMJ (1991) 1.36
Maternal reports of conscience development and temperament in young children. Child Dev (1994) 1.36
Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant (2009) 1.35
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest (1999) 1.35
The efficacy of several endodontic irrigating solutions: a scanning electron microscopic study: Part 2. J Endod (1982) 1.35
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 1.35
Evidence for reversible microclustering of lentil lectin membrane receptors on HeLa cells. FEBS Lett (1980) 1.34
Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis. BJOG (2013) 1.34
B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol (1994) 1.33
Behavior trends of wives of alcoholics. Q J Stud Alcohol (1971) 1.33
The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med (1992) 1.32
Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Immunology (1992) 1.32
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 1.32
Cholescintigraphy, ultrasonography and computerized tomography in the evaluation of biliary tract disorders. Semin Nucl Med (1979) 1.29
Genetic analysis of Proteus mirabilis mutants defective in swarmer cell elongation. J Bacteriol (1995) 1.28
High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis (1995) 1.28
IL-10: a potential therapy for allergic inflammation? Immunol Today (1997) 1.27
Modification of glycogen synthase activity in isolated rat hepatocytes by tumor-promoting phorbol esters: evidence for differential regulation of glycogen synthase and phosphorylase. Proc Natl Acad Sci U S A (1983) 1.27
Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol (1997) 1.27
Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol (1990) 1.26
The influence of the smeared layer upon dentinal tubule penetration by plastic filling materials. J Endod (1984) 1.25
Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med (1984) 1.25
Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood (2000) 1.25
Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol (1992) 1.24
Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob Agents Chemother (2001) 1.24
Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol (1997) 1.24
Evaluation of the enzyme-linked immunosorbent assay (ELISA) and other serological tests for the diagnosis of toxoplasmosis. Bull World Health Organ (1980) 1.23
Nonresective treatment of abdominal aortic aneurysms. Use of acute thrombosis and axillofemoral bypass. Arch Surg (1979) 1.23
Respiratory muscle action inferred from rib cage and abdominal V-P partitioning. J Appl Physiol (1976) 1.21
Circulating immune complexes in schistosomiasis. Immunology (1977) 1.20
The efficacy of several irrigating solutions for endodontics: a scanning electron microscopic study. Oral Surg Oral Med Oral Pathol (1981) 1.20
Deposition of idiotype-anti-idiotype immune complexes in renal glomeruli after polyclonal B cell activation. J Exp Med (1982) 1.19
High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am J Clin Nutr (1991) 1.18
Bacterial contamination in platelet concentrates. Vox Sang (2014) 1.18
Immunologic analysis by quantitative fluorescent antibody methods of the effects of prolonged cultivation on Trichomonas gallinae. J Protozool (1968) 1.18
A cascade of cytokines is responsible for IL-9 expression in human T cells. Involvement of IL-2, IL-4, and IL-10. J Immunol (1995) 1.17
The influence of the smeared layer upon dentinal tubule penetration by endodontic filling materials. Part II. J Endod (1987) 1.16
N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J Immunol (1999) 1.15
Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology (1997) 1.14
Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm. Clin Exp Immunol (2005) 1.13
Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology (2000) 1.13
In vitro behavior of silicate glass coatings on Ti6A14V. Biomaterials (2002) 1.12